Radiation-Induced Sarcoma of the Breast: A Systematic Review
Identifieur interne : 003122 ( Pmc/Curation ); précédent : 003121; suivant : 003123Radiation-Induced Sarcoma of the Breast: A Systematic Review
Auteurs : Grishma R. Sheth ; Lee D. Cranmer ; Benjamin D. Smith [États-Unis] ; Lauren Grasso-Lebeau [États-Unis] ; Julie E. LangSource :
- The Oncologist [ 1083-7159 ] ; 2012.
Abstract
A systematic review of the published English-language literature was performed to evaluate evidenced-based practices for radiation-induced sarcoma treatment. Surgery with wide negative margins remains the primary treatment; the role of adjuvant and neoadjuvant chemotherapy is uncertain.
Url:
DOI: 10.1634/theoncologist.2011-0282
PubMed: 22334455
PubMed Central: 3316927
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003123
Links to Exploration step
PMC:3316927Curation
No country items
Grishma R. Sheth<affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation><affiliation><nlm:aff wicri:cut=", and" id="aff3">Department of Medicine, Division of Hematology-Oncology</nlm:aff><wicri:noCountry code="subfield">Division of Hematology-Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Radiation-Induced Sarcoma of the Breast: A Systematic Review</title><author><name sortKey="Sheth, Grishma R" sort="Sheth, Grishma R" uniqKey="Sheth G" first="Grishma R." last="Sheth">Grishma R. Sheth</name><affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation></author><author><name sortKey="Cranmer, Lee D" sort="Cranmer, Lee D" uniqKey="Cranmer L" first="Lee D." last="Cranmer">Lee D. Cranmer</name><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation><affiliation><nlm:aff wicri:cut=", and" id="aff3">Department of Medicine, Division of Hematology-Oncology</nlm:aff><wicri:noCountry code="subfield">Division of Hematology-Oncology</wicri:noCountry></affiliation></author><author><name sortKey="Smith, Benjamin D" sort="Smith, Benjamin D" uniqKey="Smith B" first="Benjamin D." last="Smith">Benjamin D. Smith</name><affiliation wicri:level="1"><nlm:aff id="aff5">Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea></affiliation></author><author><name sortKey="Grasso Lebeau, Lauren" sort="Grasso Lebeau, Lauren" uniqKey="Grasso Lebeau L" first="Lauren" last="Grasso-Lebeau">Lauren Grasso-Lebeau</name><affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pathology, University of Arizona, Tucson, Arizona, USA;</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pathology, University of Arizona, Tucson, Arizona</wicri:regionArea></affiliation></author><author><name sortKey="Lang, Julie E" sort="Lang, Julie E" uniqKey="Lang J" first="Julie E." last="Lang">Julie E. Lang</name><affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22334455</idno><idno type="pmc">3316927</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316927</idno><idno type="RBID">PMC:3316927</idno><idno type="doi">10.1634/theoncologist.2011-0282</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">003123</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003123</idno><idno type="wicri:Area/Pmc/Curation">003122</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003122</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Radiation-Induced Sarcoma of the Breast: A Systematic Review</title><author><name sortKey="Sheth, Grishma R" sort="Sheth, Grishma R" uniqKey="Sheth G" first="Grishma R." last="Sheth">Grishma R. Sheth</name><affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation></author><author><name sortKey="Cranmer, Lee D" sort="Cranmer, Lee D" uniqKey="Cranmer L" first="Lee D." last="Cranmer">Lee D. Cranmer</name><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation><affiliation><nlm:aff wicri:cut=", and" id="aff3">Department of Medicine, Division of Hematology-Oncology</nlm:aff><wicri:noCountry code="subfield">Division of Hematology-Oncology</wicri:noCountry></affiliation></author><author><name sortKey="Smith, Benjamin D" sort="Smith, Benjamin D" uniqKey="Smith B" first="Benjamin D." last="Smith">Benjamin D. Smith</name><affiliation wicri:level="1"><nlm:aff id="aff5">Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas</wicri:regionArea></affiliation></author><author><name sortKey="Grasso Lebeau, Lauren" sort="Grasso Lebeau, Lauren" uniqKey="Grasso Lebeau L" first="Lauren" last="Grasso-Lebeau">Lauren Grasso-Lebeau</name><affiliation wicri:level="1"><nlm:aff id="aff4">Department of Pathology, University of Arizona, Tucson, Arizona, USA;</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pathology, University of Arizona, Tucson, Arizona</wicri:regionArea></affiliation></author><author><name sortKey="Lang, Julie E" sort="Lang, Julie E" uniqKey="Lang J" first="Julie E." last="Lang">Julie E. Lang</name><affiliation><nlm:aff id="aff1">Department of Surgery, Division of Surgical Oncology,</nlm:aff><wicri:noCountry code="subfield">Division of Surgical Oncology</wicri:noCountry></affiliation><affiliation><nlm:aff id="aff2">Arizona Cancer Center,</nlm:aff></affiliation></author></analytic><series><title level="j">The Oncologist</title><idno type="ISSN">1083-7159</idno><idno type="eISSN">1549-490X</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>A systematic review of the published English-language literature was performed to evaluate evidenced-based practices for radiation-induced sarcoma treatment. Surgery with wide negative margins remains the primary treatment; the role of adjuvant and neoadjuvant chemotherapy is uncertain.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Oncologist</journal-id><journal-id journal-id-type="iso-abbrev">Oncologist</journal-id><journal-id journal-id-type="pmc">oncologist</journal-id><journal-id journal-id-type="hwp">theoncologist</journal-id><journal-id journal-id-type="publisher-id">The Oncologist</journal-id><journal-title-group><journal-title>The Oncologist</journal-title></journal-title-group><issn pub-type="ppub">1083-7159</issn><issn pub-type="epub">1549-490X</issn><publisher><publisher-name>AlphaMed Press</publisher-name><publisher-loc>Durham, NC, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22334455</article-id><article-id pub-id-type="pmc">3316927</article-id><article-id pub-id-type="publisher-id">3755371</article-id><article-id pub-id-type="doi">10.1634/theoncologist.2011-0282</article-id><article-categories><subj-group subj-group-type="heading"><subject>Sarcomas</subject></subj-group></article-categories><title-group><article-title>Radiation-Induced Sarcoma of the Breast: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sheth</surname><given-names>Grishma R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cranmer</surname><given-names>Lee D.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Benjamin D.</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grasso-LeBeau</surname><given-names>Lauren</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lang</surname><given-names>Julie E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><sup>a</sup>Department of Surgery, Division of Surgical Oncology,</aff><aff id="aff2"><sup>b</sup>Arizona Cancer Center,</aff><aff id="aff3"><sup>c</sup>Department of Medicine, Division of Hematology-Oncology, and</aff><aff id="aff4"><sup>d</sup>Department of Pathology, University of Arizona, Tucson, Arizona, USA;</aff><aff id="aff5"><sup>e</sup>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA</aff></contrib-group><author-notes><corresp>Correspondence: Julie E. Lang, M.D., F.A.C.S., Department of Surgery, University of Arizona, 1501 N. Campbell Avenue, Room 4327, PO Box 245131, Tucson, Arizona 85724, USA. Telephone: <phone>520-626-3970</phone>; Fax: <fax>520-626-7138</fax>; e-mail: <email>jlang@azcc.arizona.edu</email></corresp><fn fn-type="conflict"><p><bold>Disclosures: Grishma R. Sheth:</bold> None; <bold>Lee D. Cranmer:</bold> Threshold Pharmaceuticals (C/A); Merck, Altor, Amgen, Genentech, Roche, Gerson Lehrman Group (H); Supergen, Threshold, Biovex, Bristol Meyers Squibb, Progen, Ziopharm (RF); <bold>Benjamin D. Smith:</bold> UT MD Anderson Cancer Center (E); Varian Medical Systems (RF); <bold>Lauren Grasso-LeBeau:</bold> None; <bold>Julie E. Lang:</bold> Genomic Health (H); Sysmex Corp (RF).</p><p>Section Editors: <bold>Laurence Baker</bold>: BioMed Valley Discoveries, Merck (C/A); <bold>Jaap Verweij</bold>: None.</p><p>Reviewer “A”: None</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2012</year></pub-date><volume>17</volume><issue>3</issue><fpage>405</fpage><lpage>418</lpage><history><date date-type="received"><day>16</day><month>8</month><year>2011</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2011</year></date></history><permissions><copyright-statement>©AlphaMed Press</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="onc00312000405.pdf"></self-uri><abstract abstract-type="precis"><p>A systematic review of the published English-language literature was performed to evaluate evidenced-based practices for radiation-induced sarcoma treatment. Surgery with wide negative margins remains the primary treatment; the role of adjuvant and neoadjuvant chemotherapy is uncertain.</p></abstract><abstract abstract-type="objectives"><title>Learning Objectives</title><p>After completing this course, the reader will be able to:
<list list-type="order"><list-item><p>Evaluate the level of evidence to inform decision making for the treatment radiation induced sarcoma of the breast.</p></list-item><list-item><p>Explain diagnostic criteria for radiation-induced sarcoma.</p></list-item><list-item><p>Describe the effectiveness of surgery, chemotherapy and radiation therapy for radiation induced sarcoma of the breast.</p></list-item></list></p><p>This article is available for continuing medical education credit at <ext-link ext-link-type="uri" xlink:href="http://CME.TheOncologist.com">CME.TheOncologist.com</ext-link></p></abstract><abstract><sec><title>Introduction.</title><p>Radiation-induced sarcoma (RIS) is a rare, aggressive malignancy. Breast cancer survivors treated with radiotherapy constitute a large fraction of RIS patients. To evaluate evidenced-based practices for RIS treatment, we performed a systematic review of the published English-language literature.</p></sec><sec><title>Methods.</title><p>We performed a systematic keyword search of PubMed for original research articles pertaining to RIS of the breast. We classified and evaluated the articles based on hierarchal levels of scientific evidence.</p></sec><sec><title>Results.</title><p>We identified 124 original articles available for analysis, which included 1,831 patients. No randomized controlled trials involving RIS patients were found. We present the best available evidence for the etiology, comparative biology to primary sarcoma, prognostic factors, and treatment options for RIS of the breast.</p></sec><sec><title>Conclusion.</title><p>Although the evidence to guide clinical practice is limited to single institutional cohort studies, registry studies, case–control studies, and case reports, we applied the available evidence to address clinically relevant questions related to best practice in patient management. Surgery with widely negative margins remains the primary treatment of RIS. Unfortunately, the role of adjuvant and neoadjuvant chemotherapy remains uncertain. This systematic review highlights the need for additional well-designed studies to inform the management of RIS.</p></sec></abstract><kwd-group><kwd>Radiation-induced</kwd><kwd>Radiotherapy</kwd><kwd>Breast cancer</kwd><kwd>Second primary malignancy</kwd><kwd>Sarcoma</kwd><kwd>Angiosarcoma</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003122 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 003122 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:3316927
|texte= Radiation-Induced Sarcoma of the Breast: A Systematic Review
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:22334455" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |